NCT07443475 2026-03-02
Electrochemotherapy for Recurrent Vulvar Cancer
Institute of Oncology Ljubljana
Phase 2 Recruiting
Clinical Trials
10 trialsNCT07407647 2026-02-12
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Ohio State University Comprehensive Cancer Center
Phase 2 Recruiting
NCT06677190 2025-11-05
Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT05903833 2025-09-09
PIERCE
AGO Research GmbH
Phase 2 Recruiting
NCT06023862 2025-06-15
DOVE
Yonsei University
Phase 2 Recruiting
NCT05932212 2025-03-12
AK104 for Recurrent or Metastatic Vulvar Cancer
Akeso
Phase 2 Recruiting
NCT06292689 2024-11-21
A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal Cancer
Zhejiang Cancer Hospital
Phase 2 Recruiting
NCT06686043 2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2 Recruiting
NCT05076942 2023-08-01
GROINSS-VIII
University Medical Center Groningen
Phase 2 Recruiting
NCT05395962 2022-05-27
Elechtra
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2 Recruiting